Press Release: Kheiron Medical Technologies wins government grant funding to accelerate our efforts so that Mia can help when screening services start up again
Today we had the exciting news that Kheiron’s bid for an InnovateUK Government grant was successful. The grant call was for business-led innovation in response to COVID-19. Our bid is for a six month evaluation of our breast screening AI, MiaTM, in clinical settings with two existing partners.
This is to determine the best use of Mia to increase the automation of breast screening services and tackle the Covid-19 backlog, while maintaining patient safety and the standard of care.
Our CEO and co-founder Peter Kecskemethy commented:
“The current pause in breast screening services because of Covid-19 is putting women’s lives at risk. There is an expected delay of up to 12 months before normal screening resumes but we believe our breast screening AI solution, Mia, can help clinicians process the backlog and be a trusted and reliable support for NHS breast screening services. This grant will enable us to accelerate our efforts so that Mia can help when screening services start up again.”
Why screening matters
In the UK, NHS breast screening services have been stopped because of Covid-19 – In England no invitations are being sent out and Scotland, Wales and NI have stopped officially. It is expected to take 6-27 months to process the backlog of screening cases.
Statistics show that survival rates for women with screen detected breast cancer are significantly better than without. So every day, week and month that passes with screening services on hold and invitations not being sent, puts women at risk of having their breast cancer detected later.
It is therefore extremely important that screening services resume as quickly as possible and we believe that our AI breast screening solution may be able to help radiologists process the backlog of cases.
References
Article
2nd July 2021
Can AI help clear the COVID-19 breast screening backlog?
AuntMinnie.com. The impact of COVID-19 on the world of breast cancer screening has been unprecedented, with worrisome short- and long-term consequences....
Read more
PR
14th June 2021
Kheiron’s AI breast screening solution Mia® receives regulatory clearance in Australia and New Zealand
Brought to Australia and New Zealand in Partnership with AI Advance, Mia is the First and Only AI-Enabled Independent Reader for Breast Cancer Screening to receive clearance in ...
Read more
Article
13th May 2021
Healthcare Business: The role of AI and the radiologist in achieving optimal breast positioning for cancer detection
Breast positioning during image acquisition is one of the most important yet difficult aspects of breast cancer detection....
Read more
PR
30th November 2020
New results show Mia, Kheiron’s breast screening AI, could help solve the breast cancer screening workforce crisis and Covid backlog.
Today Dr Nisha Sharma and Dr Jonathan James – both NHS breast cancer radiologists and principal investigators for Kheiron Medical Technologies – presented the first int...
Read more
PR
29th November 2020
Addressing racial disparities in healthcare – New collaboration formed to develop AI for breast cancer screening on a racially diverse population of patients
Kheiron Medical Technologies and Emory University announced a collaboration today that will ensure African American women are included in the validation of a new AI ...
Read more
Blog
27th November 2020
Innovation Theatre Presentation
Listen to our co-founders talk about Mia, our AI breast screening solution...
Read more
Article
17th October 2020
Beating the cancer backlog is AI’s largest test yet
Telegraph article: Co-founders Peter Kecskemethy and Tobias Rijken were interviewed for this piece on how start-ups like Kheiron Medical and Skin Analytics are using their AI ...
Read more
PR
8th September 2020
Kheiron wins UK Government award to help solve critical challenges in UK breast screening with Mia
Today the UK Government announced the winners of its first Artificial Intelligence (AI) in Health and Care Awards and Kheiron’s bid was successful. T...
Read more
Article
21st June 2020
Defying the downturn – Kheiron CEO featured
Kheiron CEO Peter Kecskemethy was interviewed for an article in the Sunday Times business section on 21 June. The piece looked at how cash is flowing into promising health and b...
Read more